Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07680686
Clinical Trial
Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants
Not Yet Recruiting
Phase 1
View on ClinicalTrials.gov →
Summary
This study will assess how different oral formulations of ubrogepant move through the body in healthy adult participants under fasting and fed conditions.
Trial Details
NCT Number
NCT07680686
Lead Sponsor
AbbVie
Conditions
Healthy Volunteer
Enrollment
52 participants
Start Date
2026-06-30
Primary Completion
2026-10
(estimated)
Study Completion
2026-10
(estimated)
Updated on ClinicalTrials.gov
2026-07-02